Skip to main content
. Author manuscript; available in PMC: 2009 May 15.
Published in final edited form as: Trends Parasitol. 2007 Sep 7;23(10):485–493. doi: 10.1016/j.pt.2007.08.007

Table 3.

Summary of approved preventative schedules for helminthic diseases (adapted from http://whqlibdoc.who.int/publications/2006/9241547103_eng.pdf) a

Disease Treatment
LF Treat entire population at risk with ALB + DEC or ALB + IVN
LF + Onchocerciasis Treat entire population at risk with ALB + IVN
LF + Schistosomiasis Round 1: Treat entire population at risk with ALB + DEC or ALB + IVN
Round 2 (at least one week after round 1): Treat school-age children and adults at risk with PZQ
LF + STH Round 1: Treat entire population at risk with ALB + DEC or ALB + IVN
Round 2 (after 6 months): If STH prevalence ≥ 50%, treat school-age children with ALB or MEB
LF + Onchocerciasis + Schistosomiasis Round 1: Treat entire population at risk with ALB + IVN
Round 2 (at least one week after round 1): Treat school-age children and adults at risk with PZQ
LF + Onchocerciasis + STH Round 1: Treat entire population at risk with ALB + IVN
Round 2 (after 6 months): If STH prevalence ≥ 50%, treat school-age children with ALB or MEB
Onchocerciasis Treat entire population at risk in meso- & hyper-endemic communities with IVN
Onchocerciasis + Schistosomiasis Round 1: Treat entire population at risk in meso- & hyper-endemic communities with IVN
Round 2 (at least one week after round 1): Treat school-age children and adults at risk with PZQ
Onchocerciasis + STH Round 1: ALB (treat school-age children) and IVN (treat entire population at risk in meso- & hyper-endemic communities)
Round 2 (after 6 months): If STH prevalence ≥ 50%, treat school-age children with ALB or MEB
Schistosomiasis Treat school-age children and adults at risk with PZQ
Schistosomiasis + STH Round 1: ALB or MEB (treat school-age children) and PZQ (treat school-age children and adults considered at risk)
Round 2 (after 6 months): If STH prevalence ≥ 50%, treat school-age children with ALB or MEB
STH Round 1: Treat school-age children with ALB or MEB
Round 2 (after 6 months): If STH prevalence ≥ 50%, treat school-age children with ALB or MEB
a

Note: ALB = albendazole, DEC = diethylcarbamazine, IVN = ivermectin, MEB = mebendazole, PZQ = praziquantel; LF, lymphatic filariasis; STH, soil-transmitted helminths